Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0.
Vaz SC, Adam JA, Delgado Bolton RC, Vera P, van Elmpt W, Herrmann K, Hicks RJ, Lievens Y, Santos A, Schöder H, Dubray B, Visvikis D, Troost EGC, de Geus-Oei LF. Vaz SC, et al. Among authors: lievens y. Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1386-1406. doi: 10.1007/s00259-021-05624-5. Epub 2022 Jan 13. Eur J Nucl Med Mol Imaging. 2022. PMID: 35022844 Free PMC article. Review.
Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, Van Meerbeeck J, De Neve W, Rao B, van der Weide H, Lambin P. Dehing-Oberije C, et al. Among authors: lievens y. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):355-62. doi: 10.1016/j.ijrobp.2008.08.052. Epub 2008 Dec 25. Int J Radiat Oncol Biol Phys. 2009. PMID: 19095367
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients.
Nalbantov G, Kietselaer B, Vandecasteele K, Oberije C, Berbee M, Troost E, Dingemans AM, van Baardwijk A, Smits K, Dekker A, Bussink J, De Ruysscher D, Lievens Y, Lambin P. Nalbantov G, et al. Among authors: lievens y. Radiother Oncol. 2013 Oct;109(1):100-6. doi: 10.1016/j.radonc.2013.08.035. Epub 2013 Sep 14. Radiother Oncol. 2013. PMID: 24044794 Free article.
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.
Nestle U, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Slotman B, Ramella S, Faivre-Finn C, McDonald F, Manapov F, Putora PM, LePéchoux C, Van Houtte P. Nestle U, et al. Among authors: lievens y. Radiother Oncol. 2018 Apr;127(1):1-5. doi: 10.1016/j.radonc.2018.02.023. Epub 2018 Mar 28. Radiother Oncol. 2018. PMID: 29605476
Prospective data registration and clinical trials for particle therapy in Europe.
Langendijk JA, Orecchia R, Haustermans K, Zips D, Balosso J, Lacombe D, Lievens Y, Weber DC, Grau C, Troost EGC. Langendijk JA, et al. Among authors: lievens y. Radiother Oncol. 2018 Jul;128(1):9-13. doi: 10.1016/j.radonc.2018.06.001. Epub 2018 Jul 7. Radiother Oncol. 2018. PMID: 30056852 Free article. Review.
Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
van Timmeren JE, van Elmpt W, Leijenaar RTH, Reymen B, Monshouwer R, Bussink J, Paelinck L, Bogaert E, De Wagter C, Elhaseen E, Lievens Y, Hansen O, Brink C, Lambin P. van Timmeren JE, et al. Among authors: lievens y. Radiother Oncol. 2019 Jul;136:78-85. doi: 10.1016/j.radonc.2019.03.032. Epub 2019 Apr 11. Radiother Oncol. 2019. PMID: 31015133 Free PMC article.
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Guckenberger M, et al. Among authors: lievens y. Radiother Oncol. 2020 May;146:223-229. doi: 10.1016/j.radonc.2020.04.001. Epub 2020 Apr 6. Radiother Oncol. 2020. PMID: 32342863 Free PMC article.
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
Lieverse RIY, Van Limbergen EJ, Oberije CJG, Troost EGC, Hadrup SR, Dingemans AC, Hendriks LEL, Eckert F, Hiley C, Dooms C, Lievens Y, de Jong MC, Bussink J, Geets X, Valentini V, Elia G, Neri D, Billiet C, Abdollahi A, Pasquier D, Boisselier P, Yaromina A, De Ruysscher D, Dubois LJ, Lambin P. Lieverse RIY, et al. Among authors: lievens y. BMC Cancer. 2020 Jun 15;20(1):557. doi: 10.1186/s12885-020-07055-1. BMC Cancer. 2020. PMID: 32539805 Free PMC article.
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.
Le Pechoux C, Faivre-Finn C, Ramella S, McDonald F, Manapov F, Putora PM, Slotman B, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Van Houtte P, Nestle U. Le Pechoux C, et al. Among authors: lievens y. Radiother Oncol. 2020 Nov;152:89-95. doi: 10.1016/j.radonc.2020.07.012. Epub 2020 Jul 13. Radiother Oncol. 2020. PMID: 32673777 Free article.
208 results